1. Home
  2. Publications
  3. Publications of type "Paper"

Publications of type "Paper"

Enter any text in the title of the paper (e.g. 'Breast'; 'Scotland')
The full UKIACR member associated with this publication

  1. CanStaging+: an electronic staging tool for population-based cancer registries

    Isabelle Soerjomataram, Morten Ervik, Colin Fox, Sinead Hawkins, Kenneth Yeung, Giulio Napolitano, Zuzanna Tittenbrun, Freddie Bray, Anna Gavin
    2021 Aug;22(8):1069 PMID: 34339643

  2. International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials: A qualitative study

    Ameeta Retzer, Melanie Calvert, Khaled Ahmed, Thomas Keeley, Jo Armes, Julia M Brown, Lynn Calman, Anna Gavin, Adam W Glaser, Diana M Greenfield, Anne Lanceley, Rachel M Taylor, Galina Velikova, Michael Brundage, Fabio Efficace, Rebecca Mercieca-Bebber, Madeleine T King, Derek Kyte
    Aug;10(16):5475-5487 PMID: 34219395

  3. International differences in lung cancer survival by sex, histological type and stage at diagnosis; an ICBP SURVMARK-2 Study

    ICBP SURVMARK-2 Local Leads
    Thorax https://doi.org/10.1136/thoraxjnl-2020-216555

  4. Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment

    Jess Fraser, Fahmina Fardus-Reid, Lucy Irvine, Lucy Elliss-Brookes, Lorna Fern, Alison L. Cameron, Kathy Pritchard-Jones, Richard G. Feltbower, Jon Shelton, Charles Stiller, Martin G. McCabe
    Pediatric blood and Cancer https://doi.org/10.1002/pbc.29204

  5. COVID-19 in children with haematological malignancies

    Gerard Cathal Millen, Roland Arnold, Jean-Baptiste Cazier, Helen Curley, Richard Feltbower, Ashley Gamble, Adam Glaser, Richard G Grundy, Laura Kirton, Lennard Y W Lee, Martin G McCabe, Claire Palles, Bob Phillips, Charles A Stiller, Csilla Varnai, Pamela Kearns
    BMJ Journals http://dx.doi.org/10.1136/archdischild-2021-322062

  6. Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study

    Ashleigh C Hamilton, David W Donnelly, Maurice B Loughrey, Richard C Turkington, Colin Fox, Deirdre Fitzpatrick, Ciaran E O'Neill, Anna T Gavin, Helen G Coleman
    2021 Jul 1;1-8 PMID: 34211120

  7. Data Resource Profile: The Virtual Cardio-Oncology Research Initiative (VICORI) linking national English cancer registration and cardiovascular audits

    Michael J Sweeting, Clare Oliver-Williams, Lucy Teece, Catherine A Welch, Mark A de Belder, Briana Coles, Paul C Lambert, Lizz Paley, Mark J Rutherford, Lucy Elliss- Brookes, John Deanfield, Mick D Peake, David Adlam on behalf of the VICORI Collaborative
    International Journal of Epidemiology https://doi.org/10.1093/ije/dyab082

  8. Case-ascertainment of acute myocardial infarction hospitalisations in cancer patients: a cohort study using English linked electronic health data

    Coles B, Teece L, Weston C, de Belder MA, Oliver-Williams C, Welch CA, Rutherford MJ, Lambert PC, Bidulka P, Paley L, Nitsch D, Deanfield J, Peake MD, Adlam D, Sweeting MJ, VICORI collaborative
    European Heart journal https://doi.org/10.1093/ehjqcco/qcab045

  9. Describing socio-economic variation in life expectancy according to an individual's education, occupation and wage in England and Wales: An analysis of the ONS Longitudinal Study

    Fiona C. Ingleby, Laura M. Woods, Iain M. Atherton, Matthew Baker, Lucy Elliss-Brookes, Aurélien Belot
    SSM - Population Health https://doi.org/10.1016/j.ssmph.2021.100815

  10. Community prescribing for cancer patients at the end of life: a national study

    Gabrielle Emanuel, Julia Verne, Karen Forbes, Luke Hounsome , Katherine E Henson
    BMJ Supportive & Palliative Care http://dx.doi.org/10.1136/bmjspcare-2021-002952

  11. A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38-targeted monoclonal antibody therapy in England

    Ahmed Elsada, Amy Zalin-Miller, Craig Knott, Leonidas Caravotas
    eJHaem https://doi.org/10.1002/jha2.214

  12. Using the Framework Method for the Analysis of Qualitative Dyadic Data in Health Research

    Collaço, N., Wagland, R., Alexis, O., Gavin, A., Glaser, A. & Watson, E. K
    Qualitative Health Research https://doi.org/10.1177/10497323211011599

  13. The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020

    Z. C. Venables, S. Ahmed, T. O. Bleiker, J. Broggio, M. Kwiatkowska, N. J. Levell, G. W. M. Millington, L. Paley, E. Payne, C. M. Proby, S. Vernon, S. McPhail
    British Journal of Dermatology https://doi.org/10.1111/bjd.20409

  14. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes

    James W F Catto, Amy Downing , Samantha Mason, Penny Wright, Kate Absolom, Sarah Bottomley, Luke Hounsome, Syed Hussain, Mohini Varughese, Caroline Raw , Phil Kelly, Adam W Glaser
    European Urology https://doi.org/10.1016/j.eururo.2021.01.032

  15. Primary liver cancer in the UK: Incidence, incidence based mortality, and survival by subtype, sex, and nation

    Anya Burton, Daniela Tataru, Robert J. Driver, Thomas G. Bird, Dyfed Huws, David Wallace, Timothy J.S. Cross, Ian A. Rowe, Graeme Alexander, Aileen Marshall, on behalf of the HCCUK/ BASL/NCRAS Partnership Steering Group
    JHEP reports https://doi.org/10.1016/j.jhepr.2021.100232

  16. Stage–specific incidence trends of renal cancers in the East of England, 1999–2016

    Annie Herbert, Matthew E. Barclay, Minjoung M. Koo, Brian Rous, David C. Greenberg, Gary Abel, Georgios Lyratzopoulos
    Cancer epidemiology http://dx.doi.org/10.1016/j.canep.2020.101883

  17. Systematic review of the use of translated patient-reported outcome measures in cancer trials

    A. L. Slade, A. Retzer, K. Ahmed, D. Kyte, T. Keeley, J. Armes, J. M. Brown, L. Calman, A. Gavin, A. W. Glaser, D. M. Greenfield, A. Lanceley, R. M. Taylor, G. Velikova, G. Turner and M. J. Calvert
    2021 Apr 26;22(1):306. PMID: 33902699

  18. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation

    Anya Burton, Daniela Tataru, Robert J. Driver, Thomas G. Bird, Dyfed Huws, David Wallace, Timothy J.S. Cross, Ian A. Rowe, Graeme Alexander, Aileen Marshall, on behalf of the HCC-UK/BASL/NCRAS Partnership Steering Group
    2021 Jan 19;3(2):100232 PMID: 33748727

  19. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

    Prof Eva J A Morris, Raphael Goldacre, Enti Spata, Marion Mafham, Prof Paul J Finan, Jon Shelton, Prof Mike Richards, Katie Spencer, Prof Jonathan Emberson, Sam Hollings, Paula Curnow, Dominic Gair, Prof David Sebag-Montefiore, Prof Chris Cunningham, Prof Matthew D Rutter, Brian D Nicholson, Jem Rashbass, Prof Martin Landray, Prof Rory Collins, Prof Barbara Casadei, Prof Colin Baigent
    The Lancet Gastroenterology & Hepatology https://doi.org/10.1016/S2468-1253(21)00005-4

  20. P78.01 Nivolumab in Second Line Non-Small Cell Lung Cancer – Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057

    S Popat, N. Tanna, S. Hartridge- Lambert, C. Kiff, A. Sowdani, B. Rothwell, T. Henrik-Brodtkorb, C. Ling, R. Smittenaar, M. Bomb, A. Turnbull, S. Lawton
    Journal of Thoracic Oncology http://dx.doi.org/10.1016/j.jtho.2021.01.1164